Journal of Oncology / 2009 / Article / Fig 7

Research Article

Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer

Figure 7

IgG25 and IgG28 modulate in vivo EphA2 downstream signaling: Western Blot analyses of tumor lysates with antiphospho FAK (Tyr 576) and anti-phospho Akt. Antibodies to total Akt, total FAK, and actin were used as loading controls. values were calculated with respect to average densitometric value of group treated with control IgG.
951917.fig.007

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.